Can You Stay on the Same Dose of Mounjaro Indefinitely?

Does the titration schedule mean you have to keep going up?

Tirzepatide's standard starting point is 2.5 mg for the first four weeks, a dose whose job is settling your system rather than driving weight loss directly. After that, the SmPC describes a typical four-weekly step-up pattern, but the word 'typical' is doing real work there. Prescribers are guided by your response: if you're losing weight at a pace that's clinically appropriate and tolerating the medicine well, holding at the current strength is entirely reasonable.

Think of the upper doses as options rather than destinations. The licensed ceiling is 15 mg, but NICE's review of the trial programme noted meaningful weight reduction across a range of doses, the highest dose produced the largest average results in SURMOUNT-1, yet many participants saw substantial change at lower strengths. Your prescriber weighs the marginal benefit of stepping up against how settled you feel at the dose you're on.

If you're finding the titration question confusing, you're not alone, it's one of the things our team at the Mounjaro treatment page gets asked most often. The short answer: the schedule is a framework, not a mandate. You and your prescriber decide together.

What happens if side effects make going higher feel difficult?

Gastrointestinal symptoms (nausea, loose stools, reflux, sometimes fatigue or mild dizziness) are the most commonly reported effects and tend to be most noticeable after a dose increase or at the start of treatment. For most people they ease within one to two weeks as the body adjusts, but 'most people' is not everyone.

If a dose step-up coincides with symptoms that are genuinely disruptive, the clinical response is often to stay where you are for another four weeks rather than push through. This is not a failure of the treatment; it reflects how pharmacological titration actually works. The question of staying at 5 mg specifically comes up frequently, particularly for people who move from the starter period and find that 5 mg hits the balance point between tolerability and effect.

Severe or persistent abdominal pain (especially pain that radiates to the back) warrants prompt medical assessment rather than watchful waiting; the MHRA's Drug Safety Update programme has highlighted acute pancreatitis as an infrequent but serious consideration with GLP-1 medicines. If something feels wrong, contact a clinician rather than adjusting the dose yourself.

Can you stay on the lowest dose of Mounjaro permanently?

Clinically, yes, if the evidence at your review supports it. The question of whether the lowest dose of Mounjaro is viable long-term is a real one, and the honest answer is that it depends on your individual response. For some people the 2.5 mg or 5 mg pen delivers progress that is both meaningful and sustainable; for others those doses represent a stepping stone only.

What prescribers typically look at: is weight trending in the right direction? Are you tolerating the medicine? Is there a clinical reason to expect more from a higher dose? NICE's guidance on tirzepatide (TA1026) notes that continuing treatment should be reviewed if less than 5% weight loss is achieved after six months at the highest tolerated dose, which implies that a lower dose held for clinical reasons is a legitimate position. The threshold is about outcome, not about which rung of the schedule you're standing on.

Some readers find it useful to understand what staying on a low dose of Mounjaro looks like in practice, including how repeat prescriptions and reviews work over time. The short version: every repeat at nume involves a fresh clinical look, not a rubber stamp.

How does a prescriber decide when (or whether) to increase?

At each review, the relevant questions are roughly: How is weight progressing? How are you feeling on the current dose? Is there a specific reason (medical, practical, or personal) to stay or move? There is no points system. A prescriber who decides you're doing well at 7.5 mg and doesn't need 10 mg is making a sound clinical call, not cutting corners.

Transfer patients, or anyone considering a dose change, should be prepared to provide evidence of their current treatment and dose history, at nume this is part of every dose-increase review, in line with our clinical policy. The route to treatment through a GPhC-registered pharmacy always involves this kind of oversight; it's one of the things that separates a regulated private service from unverified sellers.

For context on how the different doses compare in real use, the 5 mg dose overview and the broader weight-loss treatment options page both cover the practical landscape. And if you're weighing up the cost of staying on a given dose over time, the treatment costs and consultation page sets out what's included in a nume prescription without hidden fees, one transparent price, no subscription.

If you'd like a prescriber to review whether your current or intended dose is the right fit, our clinical team carries out same-day assessments on every new and repeat consultation. That's the right place to start.